Ilaris

Canakinumab, Sold Under The Brand Name Ilaris, Is A Medication For The Treatment Of Systemic Juvenile Idiopathic Arthritis And Active Still's Disease, Including Adult-onset Still's Disease. It Is A Human Monoclonal